Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine

Many therapies are now available for patients with rheumatoid arthritis (RA) who have an inadequate response to methotrexate including tumor necrosis factor inhibitors, abatacept, tocilizumab, and rituximab. Clinical response to drugs varies widely between individuals. A part of this variability is...

Descripción completa

Detalles Bibliográficos
Autores principales: Daïen, Claire I., Morel, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913459/
https://www.ncbi.nlm.nih.gov/pubmed/24523570
http://dx.doi.org/10.1155/2014/386148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913459/
https://www.ncbi.nlm.nih.gov/pubmed/24523570
http://dx.doi.org/10.1155/2014/386148

Ejemplares similares